Defective maternal-fetal interaction in a murine autoimmune model

Area of Science:

• Reproductive immunology
• Maternal-fetal medicine
• Immunopathology

Background:

• Anti-cardiolipin antibodies (ACA) are linked to recurrent fetal loss, but the underlying mechanisms remain unclear.
• Previous studies established a mouse model where ACA immunization causes pregnancy failure.

Purpose of the Study:

• To investigate whether maternal or embryonic defects, or both, contribute to pregnancy loss in the presence of ACA.
• To elucidate the specific roles of the maternal uterine environment and embryonic development in ACA-induced reproductive failure.

Main Methods:

• Embryo transfer experiments were conducted using 3.5-day-old embryos from ACA-immunized and control mothers.
• Embryos were transferred into either ACA-treated or control uterine environments in pseudopregnant females.
• Pregnancy outcomes, including incidence, fetal number, and resorption rates, were assessed on day 14 of gestation.

Main Results:

• The ACA-treated uterine environment significantly impaired the implantation and development of normal embryos.
• Embryos originating from ACA-immunized mothers showed persistent developmental deficiencies even when transferred to a normal uterine environment.
• Both the maternal environment and the embryonic compartment exhibited defects following ACA exposure.

Conclusions:

• Recurrent fetal loss associated with ACA involves both maternal and embryonic defects.
• Previous exposure to ACA compromises the uterine receptivity and the intrinsic developmental capacity of embryos.
• These findings highlight the dual impact of ACA on reproductive success.